 |
|
| | A monoclonal antibody being studied in the treatment of certain types of cancer. MDX-010 is made in the laboratory and binds to the molecule CTLA-4 on T cells (a type of white blood cell). MDX-010 may block CTLA-4 and help the immune system kill cancer cells. Also called ipilimumab. |
| Previous Definitions: | maytansinoid DM4-conjugated humanized monoclonal antibody huC242, MBL, MC1R, MDL 101,731, MDR modulator CBT-1 | | Next Definitions: | MDX-060, mean, mean survival time, measles virus, measurable disease |
|
|
